Final ID: MDP1130
Ahmed Mohsin, Morton Lori, Olenchock Benjamin, Herman Gary, Wynne Chris, Marin Ethan, Tuckwell Katie, Xu Meng, Cheng Xiping, Redington Emily, Koyani Bharatkumar, Mateo Katrina, Thakur Mazhar, Devalaraja-narashimha Kishor
A Phase 2 Study Evaluating the Effects of Mivelsiran, an Investigational RNA Interference Therapeutic, on Hemorrhagic and Nonhemorrhagic Manifestations of Cerebral Amyloid AngiopathyGreenberg Steven, Parikh Neal, Lee Jin-moo, Van Etten Ellis, Van Osch Matthias, Klijn Catharina, Sostelly Alexandre, Goteti Sasikiran, Sepehrband Farshid, Avbersek Andreja, Deering Robert